Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety

Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

Detalles Bibliográficos
Autores principales: Jørgensen, Astrid‐Helene Ravn, Holm, Jesper Grønlund, Thomsen, Simon Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752321/
https://www.ncbi.nlm.nih.gov/pubmed/33363841
http://dx.doi.org/10.1002/ccr3.3090
_version_ 1783625836493012992
author Jørgensen, Astrid‐Helene Ravn
Holm, Jesper Grønlund
Thomsen, Simon Francis
author_facet Jørgensen, Astrid‐Helene Ravn
Holm, Jesper Grønlund
Thomsen, Simon Francis
author_sort Jørgensen, Astrid‐Helene Ravn
collection PubMed
description Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
format Online
Article
Text
id pubmed-7752321
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77523212020-12-23 Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety Jørgensen, Astrid‐Helene Ravn Holm, Jesper Grønlund Thomsen, Simon Francis Clin Case Rep Case Reports Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease. John Wiley and Sons Inc. 2020-09-10 /pmc/articles/PMC7752321/ /pubmed/33363841 http://dx.doi.org/10.1002/ccr3.3090 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Jørgensen, Astrid‐Helene Ravn
Holm, Jesper Grønlund
Thomsen, Simon Francis
Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
title Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
title_full Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
title_fullStr Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
title_full_unstemmed Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
title_short Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn’s disease: Report and systematic literature review of effectiveness and safety
title_sort guselkumab for hidradenitis suppurativa in a patient with concomitant crohn’s disease: report and systematic literature review of effectiveness and safety
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752321/
https://www.ncbi.nlm.nih.gov/pubmed/33363841
http://dx.doi.org/10.1002/ccr3.3090
work_keys_str_mv AT jørgensenastridheleneravn guselkumabforhidradenitissuppurativainapatientwithconcomitantcrohnsdiseasereportandsystematicliteraturereviewofeffectivenessandsafety
AT holmjespergrønlund guselkumabforhidradenitissuppurativainapatientwithconcomitantcrohnsdiseasereportandsystematicliteraturereviewofeffectivenessandsafety
AT thomsensimonfrancis guselkumabforhidradenitissuppurativainapatientwithconcomitantcrohnsdiseasereportandsystematicliteraturereviewofeffectivenessandsafety

Ejemplares similares